Related Experiment Videos
Streptococcal DNase B is immunologically identical to superantigen SpeF but involves separate domains
A Eriksson1, B Eriksson, S E Holm
1Department of Clinical Bacteriology, Umeå University, S-901 85 Umeå, Sweden. anna.ariksson@climi.umu.se
Clinical and Diagnostic Laboratory Immunology
|January 5, 1999
Summary
This study confirms streptococcal superantigen SpeF is DNase B, demonstrating SpeF-specific antibodies inhibit DNase B activity. However, distinct epitopes mediate SpeF
Area of Science:
- Immunology
- Microbiology
- Molecular Biology
Background:
- Streptococcal superantigens are exotoxins produced by Streptococcus species.
- DNase B is an enzyme produced by Streptococcus pyogenes that degrades DNA.
- Previous studies suggested a potential identity between SpeF and DNase B.
Purpose of the Study:
- To confirm the identity of streptococcal superantigen SpeF and DNase B.
- To investigate the relationship between the enzymatic and mitogenic activities of SpeF.
- To identify distinct immune epitopes responsible for SpeF's different functions.
Main Methods:
- Utilized polyclonal SpeF-specific antisera.
- Assessed the inhibition of methyl-green DNA depolymerization by DNase B.
- Evaluated the neutralization of T-cell mitogenicity and nuclease activity of SpeF.
Main Results:
- Confirmed that SpeF is identical to DNase B.
- SpeF-specific antisera inhibited the depolymerization of DNA by DNase B.
- Distinct immune epitopes were identified for SpeF's mitogenic and nuclease activities, as sera neutralizing one activity did not always neutralize the other.
Conclusions:
- Streptococcal superantigen SpeF is confirmed to be identical to DNase B.
- The T-cell mitogenicity and nuclease activity of SpeF are mediated by separate immune epitopes.
- This finding has implications for understanding Streptococcus pathogenesis and developing targeted therapies.